Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
scientific article published on 13 April 2018
Author/s
author: Sara Pusceddu, Davide Campana, Nicola Fazio, Alberto Bongiovanni, Nicole Brighi, Silvio Ken Garattini, Luca Giacomelli, Vincenzo Mazzaferro, Filippo de Braud, Annamaria Colao, Chiara De Divitiis, Salvatore Tafuto, Sara Massironi, Federica Cavalcoli
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.